Pharmacy residents and students as an adjunct to current smoking cessation education

Main Article Content

Andrea S. Franks
Carrie B. Givens
Amy Barger-Stevens



Objective: The purpose of this study was to evaluate the impact of individualized tobacco cessation counseling provided by pharmacy residents and students to patients in the inpatient setting at an academic medical center.

Methods: Documented tobacco users were evaluated for study inclusion. The intervention group received counseling specific to their readiness to quit. After discharge, patients in the intervention group received weekly phone calls for additional counseling and data collection. One month after discharge, the standard therapy group received one phone call for data collection.

Results: No significant differences were found between groups for demographic variables or number of years smoking. At baseline, the intervention group reported significantly fewer quit attempts and more packs per day than the control group. The odds ratio (OR) for the primary outcome, abstinence, was 1.68 [95%CI=0.29:9.748] favoring the intervention group. The OR for patients using outpatient pharmacotherapy was 3.20 [95%CI=0.484:21.167] for the intervention group compared to the control group. The percentage of patients using outpatient treatment programs was 5.26% in the control group vs. 0% in the intervention group.

Conclusions: Results showed a trend toward significance for abstinence and increased use of outpatient pharmacotherapy; however, our sample size and study period limit conclusions that may be drawn. Further study is warranted for definitive results.


Download data is not yet available.
Abstract 733 | PDF Downloads 662


1. Centers for Disease Control and Prevention. Smoking-Attributable Mortality, Years of Potential Life Lost, and Productivity Losses -- United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008;57(45):1226-1228.

2. The Joint Commission. Performance Measurement. Performance Measurement Initiatives—Treating Tobacco, Alcohol and Other Drug Use. Available from: (accessed 2012 Feb 22)

3. Healthy People 2020. Tobacco Use. Available from: (accessed 2012 Feb 22)

4. Leschisin RK, Martin BA. Pharmacist-facilitated tobacco-cessation services in an inpatient setting. Am J Health Syst Pharm. 2007;64(22):3286-3289.

5. Stack NM, Zillich AJ. Implementation of inpatient and outpatient tobacco-cessation programs. Am J Health Syst Pharm. 2007;64(19):2074-2079.

6. Rx for Change: Clinician-Assisted Tobacco Cessation. San Fransisco, CA: University of California San Francisco, 1999-2012. Available from: (accessed 2012 Feb 22)

7. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38-48.

8. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. 2008. Available at: (accessed 2012 Feb 22)

9. Fagerström KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerström Tolerance Questionnaire. J Behav Med. 1989;12(2):159-182.

10. Philbrick AM, Newkirk EN, Farris KB, McDanel DL, Horner KE. Effect of a pharmacist managed smoking cessation clinic on quit rates. Pharm Pract (Internet). 2009;7(3):150-156.

11. Vitale F. Brief intervention protocol for assisting patients with tobacco cessation. Am J Health-Syst Pharm. 2007;64(24):2583-2584.

12. Ragucci KR, Shrader SP. A method for educating patients and documenting smoking status in an electronic medical record. Ann Pharmacother. 2009;43(10):1616-1620.

13. Dent LA, Harris KJ, Noonan CW. Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother. 2009;43(2):194-201.